[1]CurrentPatentAssignee:ELILILLY&CO-WO2005/42515,2005,A1Locationinpatent:Page/Pagecolumn15-16
[1]CurrentPatentAssignee:ELILILLY&CO-WO2005/42515,2005,A1Locationinpatent:Page/Pagecolumn15-16
[2]CurrentPatentAssignee:ELILILLY&CO-WO2005/42515,2005,A1Locationinpatent:Page/Pagecolumn22-23
[1]CurrentPatentAssignee:ELILILLY&CO-WO2003/91226,2003,A1Locationinpatent:Page/Pagecolumn124
[1]CurrentPatentAssignee:ELILILLY&CO-WO2003/91226,2003,A1Locationinpatent:Page/Pagecolumn112
[1]CurrentPatentAssignee:VANDAPHARMACEUTICALSINC;ELILILLY&CO-WO2008/79600,2008,A1Locationinpatent:Page/Pagecolumn3-4
Title: In vitro and ex vivo autoradiography of the NK-1 antagonist [³H]-LY686017 in Guinea pig brain.
Journal: Neuropeptides 20110401
Title: Development of the 2nd generation neurokinin-1 receptor antagonist LY686017 for social anxiety disorder.
Journal: European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology 20100201
Title: Findings on alcohol dependence point to promising avenues for targeted therapies.
Journal: JAMA 20090422
Title: Psychopharmacology. Tackling alcoholism with drugs.
Journal: Science (New York, N.Y.) 20080411
Title: Neurokinin 1 receptor antagonism as a possible therapy for alcoholism.
Journal: Science (New York, N.Y.) 20080314
Title: [A new pharmacological treatment option for alcohol dependence discovered in transnational study: neurokinin-1 receptor antagonist as a possible therapy for alcoholism?].
Journal: Neuropsychiatrie : Klinik, Diagnostik, Therapie und Rehabilitation : Organ der Gesellschaft Osterreichischer Nervenarzte und Psychiater 20080101
Title: Gackenheimer SL, et al. In vitro and ex vivo autoradiography of the NK-1 antagonist H-LY686017 in Guinea pig brain. Neuropeptides. 2011 Apr;45(2):157-64.